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Transcription Factors (TFs) are specialized proteins that regulate 
gene expression by binding to specific DNA regulatory sequences.[1] 
TFs are grouped into families according to the structure of their 
DNA binding domains, and in many cases their interaction with the 
DNA occurs as part of multimeric complexes. It is also known that 
the DNA recognition process by many TFs is coupled to the folding 
of their DNA binding domains into well-defined secondary 
structures, typically α-helices, which create a complementary 
contacting surface with the DNA major groove. [2] In some cases, 
such as in the zinc-finger family, the α-helical folding is mediated 
by coordination of a metal ion (Zn+2) to amino acid side chains, 
typically Cys and His residues. [3]  
As a result of their central biological role, there has been a great 
interest in the development of miniaturized models of TFs capable 
of reproducing the DNA binding properties of the natural proteins. 
[ 4 , 5 ] The more successful approaches have relied either on 
engineering the DNA binding regions into pre-folded secondary 
structures, [6] or in the conjugation of these peptidic modules to other 
DNA-binding units, such as minor groove binders. [7] Also, in the 
context of mimicking nature, several groups have developed 
synthetic constructs whose DNA recognition properties can be 
modulated by application of external stimuli, such as light or metal 
ions. [8]  
Herein we present a new approach for the specific recognition of 
DNA sequences that combines in a single system many of the 
attributes of these previous designs: bivalence, conditional folding, 
responsiveness to external stimuli (metal ions), and even 
reversibility. The strategy, which relies on a planned, dual role for 
nickel (II) as both a dimerizing agent and folding promoter, involves 
a programmed self-assembly of dissimilar components. 
Design and synthesis: As starting point for our design we chose 
the yeast transcription factor GCN4, an archetypical bZIP TF that 
specifically binds to ATF/CREB (5’–ATGA(c/g)TCAT–3’) or AP1 
(5’–ATGA(c)TCAT–3’) sites as a leucine zipper-mediated dimer of 
uninterrupted -helices. [9] The DNA interaction occurs through the 
N-terminal basic regions, which undergo a transition from a 
disordered structure to an alpha helix upon DNA binding. [10] While 
an isolated basic region peptide is unable to interact to its DNA 
consensus site, we have shown that appropriate conjugation to other 
DNA binders, such as distamycin analogues or bisbenzamidines, 
results in hybrid systems that can recognize composite target sites.[7]  
Relying on these precedents, we considered an alternative 
method for connecting the basic region peptide and the minor 
groove-binding unit based on their coordination to a transition metal 
and formation of a heterodimeric complex. Moreover, we 
envisioned that an appropriate modification of the basic region 
might allow the use of the metal not only as tethering unit but also 
as a promoter of the required α-helical folding. [11] Therefore, we 
decided to make a GCN4 basic region derivative in which two 
amino acids located in consecutive helical turns are mutated to 
histidines (His). In particular, we synthesized the peptide brHis2, 
featuring the amino acids Asp226-Arg249 of the GCN4 DNA 
binding domain, but with residues Leu230 and Arg234 replaced by 
His. The addition of Ni(II) or related metal ions to this peptide 
might induce the formation of an α-helix by nucleating the N-
terminal turns, while simultaneously providing a coordination site 
for bisbenzamidine derivatives equipped with a bipyridine ligand. 
[12] Given that the bisbenzamidine binds the minor groove of A/T 
rich DNA sites, [13] the bipyridine derivative might be able to recruit 
the modified GCN4 basic region (brHis2) into the adjacent major 
groove featuring a consensus DNA binding sequence (Figure 1). [14]  
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Figure 1. Outline of the cooperative assembly strategy. (a) Unfolded 
brHis2 that will fold into an α-helix in the complex (right);  (b) 
Bisbenzamidine minor groove binder. brHis2: Aba-
DPAAHKRAHNTEAARRSRARKLQR-NH2; “bpy” : bipyridine chelator 
tethered to the bisbenzamidine; and Aba: 4-Acetamidobenzoic acid. 
The GCN4-based peptide brHis2 was synthesized following 
standard SPPS procedures. On the other hand, we synthesized two 
bisbenzamidine-bipyridine derivatives featuring linkers of different 
lengths between the DNA-binding bisbenzamidine and the 
bipyridine ligand (3a and 3b); both constructs were assembled from 
the aminobisbenzamidine 1, which was synthesized in three steps 
from commercial products (Scheme 1 and supporting information). 
 
Scheme 1: Synthesis of bipyridine-bisbenzamidine derivatives for 
coordination with the GCN4-based peptide. 
DNA binding studies: The DNA binding properties of the synthetic 
constructs were studied by electrophoretic mobility assays (EMSA) 
in polyacrylamide gel under non-denaturing conditions, and using 
SybrGold as DNA stain. As expected, incubation of peptide brHis2 
in the presence of bisbenzamidines 3a or 3b, with the ds-
oligonucleotide AP1hs•A/T, which contains the consensus target 
sequences in adjacent positions, does not induce the formation of 
retarded bands in the gel (Figure 2a, lane 2). However, addition of 
increasing concentrations of Ni(ClO4)2 to the previous mixtures 
generates clear retarded bands (Figure 2a, lanes 3-5). In the case of 
3b these bands are fainter and show some smearing (Figure 2a, lanes 
6-8), and therefore the bisbenzamidine 3a was chosen for further 
characterization. In agreement with the proposed interaction model, 
no new slower-migrating bands were observed when the mixtures 
do not include the minor groove binding component 3a (figure 2b, 
lane 2); but the formation of the retarded band is again restored if 3a 
is added to the mixture of the other components (Figure 2b, lanes 3-
5). This result confirms the requirement of the bipyridine-equipped 
minor groove anchor for specific DNA binding of the peptide 
moiety. It was also interesting to observe that the complex can also 
be assembled upon addition of increasing amounts of brHis2 onto a 
mixture of AP1hs•A/T, Ni(II) and 3b (Figure 2, lanes 7-9). 
Taken together, these results indicate that the system 
dynamically assembles independently of the order in which the 
components are mixed, and any potential competitive homodimeric 
[(brHis2)2Ni]
2+ or [(3a)2Ni]
2+ species are kinetically labile and 
evolve towards the desired [(brHis2)(3a)Ni]
2+ complex in the 
presence of the target DNA oligo AP1hs•A/T. 
We next performed a forward titration by adding premixed 
combinations of equimolecular amounts of brHis2, 3a, and 
Ni(ClO4)2 (5 equiv), to a 
32P-labeled AP1hs•A/T dsDNA 
oligonucleotide. Considering the [(brHis2)(3a)Ni]
2+ complex as a 
single species binding to the DNA we could calculate an 
approximate dissociation constant around 0.45 M at 4 ºC (Figure 
3a), albeit we acknowledge that this is an oversimplification of a 
much more complex equilibrium.[7e]  
 
 
Figure 2. Comparative EMSA analysis of the DNA binding processes. 
a) Lanes 1-8: AP1
hs
•A/T (0.1 M); lane 2-5: 1 M of brHis2 and 3a, 
lanes 3-5: 0.6, 1 and 1.6 M of Ni(ClO4)2; lanes 6-8: 1 M of brHis2 
and 3b, lanes 6-8: 0.6, 1 and 1.6 M of Ni(ClO4)2; b) Lanes 1-9: 
AP1
hs
•A/T (0.1 M); lane 2-5: 0.8 M of brHis2 and 1.6 M of 
Ni(ClO4)2; lanes 3-5: 0.8, 1 and 1.6 M of 3a; lane 6-9: 0.8 M of 3a 
and 1.6 M of Ni(ClO4)2; lanes 7-9: 0.8, 1 and 1.6 M of brHis2. The 
protocol for fluorescence EMSAs involved addition of peptide 
solutions in 20 mM Tris-HCl pH 7.5 to 18 mM Tris-HCl pH 7.5, 90 mM 
KCl, 1.8 mM MgCl2, 9% glycerol 0.11 mg.mL
-1
 BSA, 2.25% NP-40 
and 100 nM of DNA (4 ºC, 30 min) and loading into the gel. Products 
were resolved by PAGE on a 10% nondenaturing polyacrylamide gel 
and 0.5X TBE buffer over 40 min at 4 ºC and by staining with 
SybrGold (5 µL in 50 mL of TBE) for 10 min, followed by fluorescence 
visualization. Note: we needed to run the EMSA in the absence of 
EDTA to avoid sequestration of the nickel cation, this is the reason of 
the smearing of the bands. Oligo sequence AP1
hs
•A/T: 5'–ACGAACG 
TCAT•AATTT CCTC –3' (peptide binding site in italics and minor 
groove binding site underlined, only one strand shown). 
We next studied the sequence selectivity of the system by using 
other dsDNAs containing specific mutations. Not surprisingly, with 
DNAs like AP1hs•mA/T (TCAT•AGTTT), which lack the A/T rich 
tract required for binding of the minor groove agent, we do not 
observe the formation of retarded bands. Moreover, we neither 
observe stable DNA complexes with oligonucleotides mutated in the 
recognition site of the peptide (mAP1hs•A/T, TCGT•AATTT). This 
result contrasts with previously studied covalent derivatives that do 
bind to these DNAs with a substantial affinity. [7c,d] 
The system is even capable of discerning sequences that feature 
shorter A/T rich binding regions, such as in AP1hs•sA/T 
(TCAT•AATT) (Figure 3c). This selectivity could be ascribed to the 
lower affinity of 3a for AATT versus AATTT, as revealed by 
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fluorescence titration experiments (KD ≈ 0.17 M for AP1
hs•sA/T, 
versus a KD ≈ 0.035 M with AP1
hs•A/T, see the supporting 
information). [15]  
The above observations highlight the higher specificity 
attainable through cooperative recognition in noncovalent 
multicomponent systems. 
Not surprisingly, a truncated derivative of the basic region 
lacking the N-terminal capping motif (Asp-Pro-Ala)[ 16 ] failed to 
promote the formation of retarded bands in EMSA experiments (see 
the supporting information). Likewise, a related GCN4 basic region 
peptide, featuring a cysteine residue instead of the histidine at 
position 230, also failed to yield the desired DNA-binding assembly, 
either in the presence of nickel, or of other metal ions (see the 
supporting information).  
 
Figure 3. a) Radioactive EMSA titration of with the mixture of the 
target dsDNA with a mixture of brHis2, 3a and Ni(ClO4)2: Lanes 1-10: 
AP1
hs
•A/T (50 nM, ~ 100 pM labeled with P
32
); Lanes 2-10: 0.1, 0,2, 
0.3, 0.4, 0.5, 0.6, 0.7, 0.8 and 1 M of a equimolecular mixture of 
brHis2 and 3a, in presence of 5 equiv of Ni(ClO4)2. b-e) EMSA 
analysis (SybrGold staining) of the DNA selectivityLanes 1-5 in gels 
b-e contain the indicated ds-oligonucleotide (0.1 M) and 0, 0.2, 0.4, 
0.6 and 0.8 M of an equimolecular mixture of brHis2 and 3a, with 5 
equiv of Ni(ClO4)2. b) AP1
hs
•A/T. c) AP1
hs
•sA/T. d) mAP1
hs
•A/T. e) 
AP1
hs
•mA/T. Oligonucleotide sequences (only one strand is shown) : 
AP1
hs
•sA/T: 5'–ACGAACG TCAT•AATT CCTC–3', mAP1
hs
•A/T: 5'–
ACGAACG TCGT•AATTT CCTC–3', AP1
hs
•mA/T: 5'–ACGAACG 
TCAT•AGTTT CCTC-3’.  
We also studied the selectivity of the system with regard to the 
metal ion (Co2+, Ni2+, Cd2+, Zn2+, Cu2+, Hg2+, and Fe2+ salts). Using 
comparable conditions, we only observed the formation of slower-
migrating bands in the presence of Ni2+ (see the supporting 
information). Therefore it seems that nickel has the right 
coordination properties to promote an effective heterodimeric 
assembly in the presence of the cognate DNA. [17] 
As expected for a rather unstructured peptide, the circular 
dichroism spectrum of brHis2, even in the presence of 3a and 
AP1hs•A/T, presents a relatively weak negative signal at 222 nm 
(Figure 4 left, curve b); addition of Ni(ClO4)2 to the mixture 
promotes a considerable increase of the negative ellipticity intensity 
at 222 nm, consistent with the folding of the peptide chain into an α-
helical conformation (Figure 4 left, curve c). [18]  
The key role of the nickel ion as adaptor component mediating 
the assembly of the system prompted us to check the possibility of 
dismounting the DNA complex by using an external nickel chelator. 
Achieving stimuli-responsive reversibility in DNA binders is a main 
challenge that cannot be easily accomplished.[8] Gratifyingly, 
addition of 10 equiv of EDTA to the supramolecular complex 
resulting from mixing brHis2, 3a, Ni
2+ and AP1hs•A/T promoted a 
drastic decrease in the helicity of the peptide (Figure 4 left, curve d), 
which correlates with the disruption of the DNA complex, as 
demonstrated by EMSA experiments (inset in the figure). Therefore, 
while the presence of nickel is critical for the DNA interaction, the 
resulting multicomponent supramolecular complex can be 
dismounted by the addition of an external nickel chelator. 
 
 
Figure 4. Left: Circular dichroism spectra of different components in 
presence of AP1
hs
•A/T (5 µM) in Tris-HCl buffer 20 mm, pH 7.5, NaCl 
100 mm at 20ºC. a): 3a (5 µM); b): 3a (5 µM) and brHis2 (5 µM); c): 
3a (5 µM), brHis2 (5 µM) and Ni(ClO4)2 (10 µM); d): same as c) after 
addition of 20 equiv of EDTA; 30 equiv of EDTA leads to a full 
recovery of the initial helicity (data not shown). Inset: EMSA analysis 
(SybrGold staining). Lanes 1-3: AP1
hs
•A/T (100 nM); lane 2: 1000 nM 
of brHis2 and 3a, and 5 equiv of Ni(ClO4)2; lane 3: 1 M of brHis2 and 
3a, and 5 equiv of Ni(ClO4)2 after addition of 1.8 mM of EDTA. Right: 
Circular dichroism spectra of 3a (5 µM) and brHis2 (5 µM): a): in 
presence of 2 equiv of Ni(ClO4)2; b) same as in a) after addition of the 
consensus DNA AP1
hs
•A/T; c) same as in a) after addition of the 
mutated mAP1
hs
•A/T oligonucleotide. The contribution of the 
AP1
hs
•A/T oligo has been subtracted from the spectra. 
Importantly, control experiments showed that mixing Ni(ClO4)2 
with the peptide brHis2 does not promote an α-helical folding, even 
in the presence of the bispyridine partner 3a (Figure 4 right, curve a). 
However, addition of the DNA AP1hs•A/T to this mixture induces 
the formation of the α-helix (Figure 4 right, curve b). As expected, a 
mutated ds oligonucleotide (mAP1hs•A/T) does not induce such 
folding (Figure 4 right, curve c). Therefore, the presence of Ni(II) is 
not sufficient for inducing the folding transition of the peptide into 
an α-helix, which also requires the template effect of the target DNA. 
In summary, we have introduced a new approach for achieving a 
highly selective, bivalent recognition of designed nine DNA base 
pairs. The strategy involves the nickel-promoted assembly of 
instructed components consisting of a bishistidine-modified peptide 
derived from a bZIP transcription factor, and a bisbenzamidine 
equipped with a bipyridine unit. Key for the success of the approach 
is the dual role of the metal as an α-helix-nucleating factor and as 
heterodimerizing staple. The multicomponent nature of the system, 
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and the kinetic lability of the metal coordination, facilitates the 
disassembly of the supramolecular structure upon addition of 
external agents that sequester the nickel cation. Overall, we have 
devised a supramolecular system with emergent properties that 
reproduces some key characteristics of naturally occurring DNA 
binding proteins, such as bivalence, selectivity, responsiveness to 
external agents and reversibility. The system represents an 
infrequent case of self-assembly, as it involves four different 
components: a metal, a peptide, a small molecule and a nucleic acid. 
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Org. Lett. 2009, 12, 216–219; b) O. Vazquez, M. I. Sanchez, J. L. 
Mascarenas, M. E. Vazquez, Chem. Commun. 2010, 46, 5518–5520; 
c) M. I. Sanchez, O. Vazquez, J. Martinez-Costas, M. E. Vazquez, J. 
L. Mascarenas, Chem. Sci. 2012, 3, 2383–2387; d) J. Bordello, M. I. 
Sánchez, M. E. Vázquez, J. L. Mascareñas, W. Al-Soufi, M. Novo, 
Angew. Chem. Int. Ed. 2012, 124, 7659–7662; Angew. Chem. 2012, 
124, 7659-7662.  
[14] To design the synthetic targets we used as reference the X-ray 
structural information of the DNA complexes of GCN4 (pdb ID 
1YSA) and pentamidine (pdb ID 1D64), and information from 
previous work with other conjugates (reference 7). 
[15] These fluorescence experiments are carried out in aqueous buffers, 
under much less stringent conditions than those used in EMSA. 
[16] J. J. Hollenbeck, D. L. McClain, M. G. Oakley, Protein Sci. 2002, 11, 
2740–2747.  
[17] For Ni(II)-promoted biomolecular folding or assembly processes, see: 
a) R. J. Radford, F. A. Tezcan, J. Am. Chem. Soc. 2009, 131, 9136–
9137; b) M. Kalek, A. S. Madsen, J. Wengel, J. Am. Chem. Soc., 2007, 
129, 9392–9400; c) M. R. Ghadiri, C. Choi, J. Am. Chem. Soc., 1990, 
112, 1630–1632. 
[18] J. T. Pelton, L. R. McLean, Anal. Biochem. 2000, 277, 167–176. 
 
 
 
 
 5 
Entry for the Table of Contents 
 
Assembly at the DNA 
 
Nickel (II) salts promote the assembly, 
at specific DNA sites, of instructed 
components consisting of a bis-
histidine-modified peptide derived from 
a bZIP transcription factor, and a 
bisbenzamidine unit equipped with a 
bipyridine. This programmed 
supramolecular system with emergent 
properties reproduces some key 
characteristics of naturally occurring 
DNA binding proteins, such as 
bivalence, selectivity, responsiveness to 
external agents and reversibility. 
 
M. I. Sánchez, J. Mosquera, A/Prof. M. 
E. Vázquez,* Prof. J. L. Mascareñas* 
__________ Page – Page 
Reversible supramolecular assembly 
at specific DNA sites: Ni-promoted, 
bivalent DNA binding with designed 
peptide and bipyridyl-bisbenzamidine 
components 
 
 
